We recently published an article titled Market Slump Drags Down Share Prices of These 15 Companies. In this article, we are ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were up 3.6% during mid-day trading on Thursday . The company ...

Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years.

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Lots has happened this past week in the tech world! With artificial intelligence being called a leader in the tech market in ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $28.15 which represents a slight increase of $0.55 or 1.99% from the prior close of $27.6. The stock opened at $27.97 and ...

Delving into the details, we found 11% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...

Buy HIMS near 25.88 target 32.47 stop loss @ 25.81 Details The technical summary data tells us to buy HIMS near 25.88 with an ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Others are now out of business. There were some breakout stars, like Hims & Hers Health, which was buoyed by the success of its popular new weight loss offering and its position in the GLP-1 craze.

The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli Lilly's weight ...